Literature DB >> 26953219

The Responsiveness of the Anxiety Inventory for Respiratory Disease Scale Following Pulmonary Rehabilitation.

Abebaw M Yohannes1, Sheila Dryden2, Nicola A Hanania3.   

Abstract

BACKGROUND: To date, there are no studies that have examined the responsiveness of the Anxiety Inventory for Respiratory disease (AIR) scale to any intervention in patients with COPD. We examined the responsiveness of the AIR scale in an 8-week pulmonary rehabilitation (PR) program.
METHODS: A total of 192 patients with COPD who were clinically stable and had a percent predicted FEV1 < 70% completed 8-week outpatient multidisciplinary PR. The duration of the program was 2 h per/week (1 h exercise and 1 h education). Pre- and postrehabilitation outcome measures were evaluated: exercise capacity by the incremental shuttle walk test, quality of life by the St Georges Respiratory Questionnaire (SGRQ), and severity of dyspnea by the Medical Research Council (nMRC) scale. Anxiety was measured using the self-administered AIR scale.
RESULTS: The mean (SD) age was 71 (8.4) years and 51% were women. The AIR scale was responsive to PR with (AIR ≥ 8, high anxiety load) a mean change pre- vs post scores (12.25 vs 6.70, t = 7.56, P < .001), in incremental shuttle walk test (183 vs 258, t = 9.49, P < .001), in total SGRQ score (62.54 vs 55.70, t = 4.77, P < .001) and in nMRC score (3.32 vs 3.04, t = 2.57, P = .03) following PR. Change in AIR was significantly correlated with change in total SGRQ (r = 0.16, P = .02) and in nMRC (r = 0.15, P = .03). The effect size for the AIR was 1.01 and minimal clinical important difference was 5.55. Anxiety is a predictor of noncompletion of PR.
CONCLUSIONS: The AIR scale is sensitive to change following PR in patients with COPD and can be used in future studies evaluating interventions that reduce anxiety in this disease.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIR; COPD; anxiety; comorbidity; disability; dyspnea; quality of life

Mesh:

Year:  2016        PMID: 26953219     DOI: 10.1016/j.chest.2016.02.658

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Test Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease.

Authors:  Anna M Baker; Janet T Holbrook; Abebaw M Yohannes; Michelle N Eakin; Elizabeth A Sugar; Robert J Henderson; Anne S Casper; David A Kaminsky; Alexis L Rea; Anne M Mathews; Loretta G Que; Joe W Ramsdell; Lynn B Gerald; Robert A Wise; Nicola A Hanania
Journal:  Ann Am Thorac Soc       Date:  2018-08

2.  Psychometric properties of the Anxiety Inventory for Respiratory Disease in patients with COPD in China.

Authors:  Xiao-Yan Dong; Lan Wang; Yan-Xia Tao; Xiu-Li Suo; Yue-Chuan Li; Fang Liu; Yue Zhao; Qing Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-20

3.  The responsiveness of the Manchester Chronic Obstructive Pulmonary Disease Fatigue Scale to pulmonary rehabilitation.

Authors:  Abebaw Mengistu Yohannes; Sheila Dryden; Nicola Alexander Hanania
Journal:  Ther Adv Chronic Dis       Date:  2019-10-29       Impact factor: 5.091

4.  Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.

Authors:  Nicola A Hanania; Abebaw M Yohannes; Ayca Ozol-Godfrey; Michael Tocco; Thomas Goodin; Sanjay Sharma; Shahin Sanjar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.